Literature DB >> 27345585

Chromosomal instability: A common feature and a therapeutic target of cancer.

Kozo Tanaka1, Toru Hirota2.   

Abstract

Most cancer cells are aneuploid, containing abnormal numbers of chromosomes, mainly caused by elevated levels of chromosome missegregation, known as chromosomal instability (CIN). These well-recognized, but poorly understood, features of cancers have recently been studied extensively, unraveling causal relationships between CIN and cancer. Here we review recent findings regarding how CIN and aneuploidy occur, how they affect cellular functions, how cells respond to them, and their relevance to diseases, especially cancer. Aneuploid cells are under various kinds of stresses that result in reduced cellular fitness. Nevertheless, genetic heterogeneity derived from CIN allows the selection of cells better adapted to their environment, which supposedly facilitates generation and progression of cancer. We also discuss how we can exploit the properties of cancer cells exhibiting CIN for effective cancer therapy.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aneuploidy; Cancer; Chromosomal instability; Chromosome segregation; Kinetochore; Mitosis

Mesh:

Year:  2016        PMID: 27345585     DOI: 10.1016/j.bbcan.2016.06.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  33 in total

1.  Overexpression of hsa-miR-186 induces chromosomal instability in arsenic-exposed human keratinocytes.

Authors:  Jiguo Wu; Ana P Ferragut Cardoso; Vanessa A R States; Laila Al-Eryani; Mark Doll; Sandra S Wise; Shesh N Rai; J Christopher States
Journal:  Toxicol Appl Pharmacol       Date:  2019-06-06       Impact factor: 4.219

Review 2.  The evolutionary significance of polyploidy.

Authors:  Yves Van de Peer; Eshchar Mizrachi; Kathleen Marchal
Journal:  Nat Rev Genet       Date:  2017-05-15       Impact factor: 53.242

Review 3.  Tools used to assay genomic instability in cancers and cancer meiomitosis.

Authors:  Jennifer Gantchev; Brandon Ramchatesingh; Melissa Berman-Rosa; Daniel Sikorski; Keerthenan Raveendra; Laetitia Amar; Hong Hao Xu; Amelia Martínez Villarreal; Daniel Josue Guerra Ordaz; Ivan V Litvinov
Journal:  J Cell Commun Signal       Date:  2021-11-29       Impact factor: 5.908

Review 4.  Roles of pRB in the Regulation of Nucleosome and Chromatin Structures.

Authors:  Chiharu Uchida
Journal:  Biomed Res Int       Date:  2016-12-22       Impact factor: 3.411

5.  Translocation Breakpoints Preferentially Occur in Euchromatin and Acrocentric Chromosomes.

Authors:  Cheng-Yu Lin; Ankit Shukla; John P Grady; J Lynn Fink; Eloise Dray; Pascal H G Duijf
Journal:  Cancers (Basel)       Date:  2018-01-08       Impact factor: 6.639

6.  Comprehensive analyses of somatic TP53 mutation in tumors with variable mutant allele frequency.

Authors:  Alexander J Cole; Ying Zhu; Trisha Dwight; Bing Yu; Kristie-Ann Dickson; Gregory B Gard; Jayne Maidens; Susan Valmadre; Anthony J Gill; Roderick Clifton-Bligh; Deborah J Marsh
Journal:  Sci Data       Date:  2017-09-05       Impact factor: 6.444

7.  DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy.

Authors:  Silvia Carloni; Giulia Gallerani; Anna Tesei; Emanuela Scarpi; Giorgio Maria Verdecchia; Salvatore Virzì; Francesco Fabbri; Chiara Arienti
Journal:  Onco Targets Ther       Date:  2017-09-20       Impact factor: 4.147

Review 8.  The Role of Chromosomal Instability in Cancer and Therapeutic Responses.

Authors:  Natalia Vargas-Rondón; Victoria E Villegas; Milena Rondón-Lagos
Journal:  Cancers (Basel)       Date:  2017-12-28       Impact factor: 6.639

9.  Disseminated tumour cells with highly aberrant genomes are linked to poor prognosis in operable oesophageal adenocarcinoma.

Authors:  Sarah Schumacher; Christoph Bartenhagen; Martin Hoffmann; Daniel Will; Johannes C Fischer; Stephan E Baldus; Christian Vay; Georg Fluegen; Levent Dizdar; Daniel Vallböhmer; Christoph A Klein; Wolfram T Knoefel; Nikolas H Stoecklein; Birte Möhlendick
Journal:  Br J Cancer       Date:  2017-07-20       Impact factor: 7.640

10.  Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer.

Authors:  Hung-Wei Pan; Hsing-Hao Su; Chao-Wen Hsu; Guan-Jin Huang; Tony Tong-Lin Wu
Journal:  Onco Targets Ther       Date:  2017-07-17       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.